Understanding the gap between expectations and reality in decentralized clinical trials.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40615632.
- Also identified by DOI 10.1038/s41746-025-01811-y and PMC identifier 12227689.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Decentralized clinical trials (DCTs) have gained long-standing interest, yet their adoption as a new paradigm remains uncertain even with broader acceptance from regulatory and industry. This study aims to unveil its evolutional trend, which helps answer what the current development stage DCT is located at as well as the underlying reasons. While DCTs' prime time has not arrived, we propose solutions to advance their sustainable implementation.